genetics pathogenesis clinical interventions type diabetes
type diabetes autoimmune disorder afflicting millions people worldwide diagnosed patients require lifelong insulin treatment can experience numerous disease-associated complications last decade seen tremendous advances elucidating causes treatment disease based extensive research rodent models spontaneous diabetes humans integrating advances led recognition balance regulatory effector t cells determines disease risk timing disease activation disease tempo describe current progress challenges ahead new interventions tested address unmet need preventative curative therapies
